Clinical Trial Update: Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases

View source ↗

Summary

A completed clinical trial evaluating genomic signatures to predict outcomes for patients with initially unresectable colorectal liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Genomic Instability, Prognostic Cancer Model | Status: COMPLETED